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Abstract   
 
Acute stroke care (ASC) has undergone momentous changes in recent years with the 
introductions of intravenous thrombolysis, mechanical thrombectomy and integrated 
stroke services. While these are welcome developments, they also carry unique 
medico-legal challenges. In 2015, a patient from Greater Manchester was awarded over 
£1 million in compensation after ambulance paramedics failed to admit her to a 
specialist unit. This paper explores the medico-legal implications of this first but over-
looked thrombolysis-related claim in the United Kingdom. It is submitted that the highly 
time-dependent and multidisciplinary nature of ASC may  expose a host of healthcare 
personnel, both medical and non-medical, to risks of legal pursuit for failing to provide 
appropriate care, and that available scientific evidence will likely support such claims. 
The situation calls for an urgent and concerted effort at implementing improvement 
measures at national levels. A reminder of the legal consequences of substandard ASC 
is timely and necessary. (150 words) 
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Malpractice litigation in acute stroke care  – where are we now? 
 
 
Introduction 
 
The introduction of intravenous thrombolysis, mechanical thrombectomy and integrated 
stroke services have drastically transformed acute stroke care (ASC) in recent years.1 
Around the world, national strategies and clinical guidelines have been formulated that 
emphasise these approaches. While these are welcome developments, they may also 
introduce the possibility of related malpractice claims if healthcare professionals deviate 
from the guidance. Although a number of learned commentaries on the medico-legal 
aspects of stroke treatment are already available in the literature,2-3 medical advances  
continue to establish new standards and challenge current thinking on  what appropriate 
ASC should be and how various parties along the care pathway may be affected. At the 
same time, changing public expectations also create new avenues for negligence  
claims as indicated by the first UK case in 2015 in which a patient was awarded over £1 
million in compensation for being taken to the wrong hospital.4 This paper aims to 
explore the medico-legal implications of this over-looked case, and discuss some of the 
appropriate policy responses that may be required.  
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Contemporary treatment for acute ischaemic stroke    
 
In acute ischaemic stroke, the interruption of blood supply to the brain by obstructing 
blood clots can cause rapid cell death, fucntional loss and significant disabilities. The 
goal of contemporary ASC is to re-establsih brain perfusion as soon as possible. Two 
treatment modalities are available: intravenous thrombolysis  (IVT) and mechanical 
thrombectomy (MT).  
 
With IVT, the offending blood clot is dissolved pharmacologically. Its clinical efficacy 
was established in 1995 where IVT resulted in a 32% relative increase in the proportion 
of patients with minimal or no disability when compared with control.5 Subsequent 
clinical trials demonstrated even more promising findings, with patients treated within 
three hours deriving the greatest benefits; those treated later had  higher risks of 
complications.6 The routine use of IVT has been approved by national agencies 
including the United States Food and Drug Administration, and the National Institute for 
Health and Care Excellence (NICE) in the United Kingdom (UK).7 With MT, the 
obstructing clot is removed mechanically using endovascular catheter-based devices. 
Its efficacy when used within six hours of symptom-onset is well established especially 
where IVT is ineffective or contraindicated.8 Though  a relatively recent development, 
MT has already been approved by professional bodies in the US, continental Europe, 
and  NICE in the UK.9 
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These momentous developments ushered in a new era of ACS that contrasts sharply 
with the previous nihilistic approach to ischaemic stroke. Complete functional recovery 
is now a realistic prospect for many patients. The dramatic benefits of IVT and MT also 
mean that  failure to provide these treatments are  likely to be seen as the cause of 
otherwise avoidable health and socio-economic losses as well as justifiable discontent 
on the part of the patient. Related malpractice claims could only be expected - and 
materialised.  
 
 
The case of Lynne Horner 
 
Worldwide,  IVT-related claims have already occurred including 46 in the United States 
(US) by 2013,3 and six in Taiwan by 2010.10 The first successful claim in the UK 
involved Lynne Horner, a 69-year-old woman from Greater Manchester who suffered a 
stroke in 2010. A rapid response paramedic initially confirmed her symptoms of slurred 
speech and confusion. An ambulance paramedic, who arrived soon after, thought that 
she was recovering and decided to take her to a non-specialist hospital instead of the 
regional stroke centre. By the time she was secondarily transferred to a specialist unit, it 
was too late for IVT. She sustained permanent paralysis. The North West Ambulance 
Service NHS Trust admitted negligence, and damages of over £1 million were awarded 
following a court hearing in 2015.4 
 
What is particularly unusual about this case is that it was not emergency or stroke 
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physicians but ambulance paramedics that were found to be at fault; it also represents 
the probable worldwide first IVT-related claim that involves failure of direct stroke unit 
admission. It throws light on how some fundamental elements of medical negligence 
apply in contemporary ASC - namely, the expansion of duty of care, the legally required 
standard of care, and the proof of causation. These will be discussed in turn.  
 
 
The expanding circle of carers 
 
Traditionally, English courts are reluctant to hold emergency service providers such as 
fire brigades and the police liable in negligence. Claims against ambulance services 
tended to be uncommon and usually unsuccessful.11 Things changed, and the present 
case reaffirms the landmark decisions in Kent v Griffiths that establishes paramedics  
owe patients a duty of care once an emergency call has been accepted.11 Since Kent, 
most claims against paramedics  involve delays and technical failures; t misdirected 
hospitalisation, as in the present case, remained unusual.  
 
The highly time-dependent, specialised and multidisciplinary nature of contemporary 
ASC is likely to expose other healthcare personnel to risks of legal claims. Apart from 
neurologists, neurosurgeons and emergency physicians, radiographers and radiology 
assistants now play critical roles in providing rapid and critical clinical investigations; 
nurse practitioners similarly participate in front-line patient triage. Failure on their part to 
discharge professional duties can delay diagnosis and treatment, and may be found 
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negligent.  Effective protocol implementation and training are essential and rewarding, if 
only for better patient care. 
 
Even informal carers could, arguably, be implicated for failure to call for medical help in 
a responsible manner, in that a person who lacks capacity, as might be the case in 
stroke, is owed a duty of care by his or her carer to act in that person’s best interest.12 
This is an onerous duty since the assessment of the neurological status and mental 
capacity of a stroke patient can be far from straightforward even for seasoned clinicians. 
A conscious but agitated patient who refuses hospitalisation, for example, may present 
family members with significant challenges; the ‘diagnosis’ of stroke in an elderly patient 
presenting with slurring of speech is no less difficult. Better public education is needed.  
 
 
The evolving standard of care 
 
Numerous Clinical Practice Guidelines (CPG) on the use of IVT and MT are available. 
However, rapid changes in medical technology, constant emergence of new clinical 
evidence and different approaches in data interpretation have led to discrepancies 
between available guidance. According to a 2015 review, for example, CPG on the use 
of IVT at 3-4.5 hours post-symptom-onset may range from “strong or weak 
recommendations for” to “weak recommendations against” or “should not be considered 
standard of care”. Treatment within three hours is uncontroversial.1  
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Mostly issued by eminent professional bodies, these CPG, while without specific legal 
status, are likely to be used by expert witnesses in formulating their opinions. In the US, 
where the ‘learned treatise doctrine’ recognises CPG as having authoritative power in 
establishing the standard of care and being admissible as substantive evidence in court, 
a number of successful IVT-related claims have already been brought.13 In England and 
Wales and elsewhere, a gradual doctrinal shift towards a greater readiness for the court 
to appraise and interpret CPG also accords them increasing weight.14 But since the 
court is not supposed to prefer one body of opinion to another, discrepancies between 
CPG may potentially lead to unpredictable and inconsistent judicial outcomes. In 
medical negligence, doctors are judged by the ‘prevailing’ standard of care, and it can 
be difficult to ascertain in this context of evolving treatment paradigms what the 
‘prevailing’ standard should be at the time when a doctor manages a stroke patient. In 
this regard, the ambulance service provider’s acceptance of breach of duty in Lynne 
Horner’s case effectively acknowledges the 2008 NICE guidance that recommends IVT 
within 4.5 hours, and, importantly, that 
 
“all people with suspected stroke should be admitted directly to a specialist acute 
stroke unit following initial assessment, either from the community or from the 
A&E department”.7 
 
Whether this will indeed become the legally required standard of care for acute 
ischaemic stroke is to be confirmed. If so, a duty would arguably  require all hospital 
trusts in England and Wales to fund specialist units of sufficient quality and implement 
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protocols so that patients can - as far as reasonably possible - be treated within the 
specified timescale; whatever the day of the week or time of day.  
 
 
Proof of causation  
 
For a claim to succeed, it must be established that the breach of duty of care has 
caused the injury at issue. Causation in medical negligence is notoriously difficult to 
prove and not least in stroke-related claims. In the recent aspirin-related case of 
Choudhury, despite the hospital trust’s admission to several counts of breach of duty, a 
claim against delayed treatment was rejected for unproven causation.15 The existing 
legal test requires the proof of a greater than 50% chance (i.e., on the balance of 
probability) that ‘but for’ the breach of duty of care, the claimant would not have 
sustained injury. A ‘loss of chance’ claim where the probability of good outcome had 
there been no breach of duty is less than 50% is unlikely to succeed.16 
 
With IVT, findings from the initial 1995 study would probably defeat any ‘loss of chance’ 
claim since the likelihood of good recovery following treatment was not found to exceed 
50%; this was indeed the basis of a successful defence in a US case.17 Subsequent 
clinical trials, however, demonstrated a greater chance of good outcome if IVT was 
given within three hours that might support future claims.18 Indeed, a 2013 systematic 
review of ‘stroke claims’ brought in non-UK jurisdictions found that judicial rulings were 
usually in favour of plaintiffs who argued that IVT would have resulted in a >50% overall 
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chance of improvement, as opposed to defendants’ counter-arguments that IVT would 
only yield a 32% greater chance of improvement.3 Although the case of Lynn Horner 
was not fought out on causation, its outcome suggests that the above could well be the 
direction of travel in the UK. A similar situation is found with MT where the likelihood of 
good functional recovery following treatment can be close to 60%.9 
 
Even when a claimant fails to establish causation under the traditional ‘but for’ test, 
damages may still be awarded if courts apply the alternative ‘material contribution’ test 
for causation. To this end, the Privy Council ruling in Williams in 2016 provides helpful 
guidance.19 It confirms the application of ‘material contribution’ to cover not only 
negligence that has materially contributed to the cause of the injury sustained (e.g., 
delayed thrombolysis, in the present context) but also negligence that has materially 
contributed to the injury itself (e.g., prolonged brain ischaemia).  
 
That said, it is important to note that a key factor in Williams was that the injury 
sustained was caused by a single known agent, namely, sepsis from a ruptured 
appendix, while the situation can be far more complex in acute stroke in that failure of 
stroke unit admission might only be one of a number of events (e.g., post-thrombolysis 
haemorrhages, pneumonia) leading up to an adverse outcome. A claim based on 
‘material contribution’ might fail if the injury may have been caused by one or more of a 
number of disparate factors, one of which was attributable to a wrongful act or omission 
by the defendant. A detailed discussion on the subtle, yet important, distinction between 
‘divisible’ and ‘indivisible’ injuries under these situations is beyond the scope of this 
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paper. It suffices to say that whether or not a defendant would be liable in full would 
depend on whether it can be established that pre-hospital delay, for example, has 
contributed to only a specific portion but not all of the injury sustained. 
 
 
Integrated stroke services and corporate responsibilities 
 
The present case highlights the importance of the provision of ASC under an effective 
system of care. The latter involves the comprehensive integration of multiple elements 
of care, ranging from the promotion of community awareness to ambulance diversion, 
secondary transfer arrangement, fast-track triage and treatment delivery at specialist 
units with adequate equipment and expertise support. It is a resource-intensive, 
logistically demanding and politically challenging endeavour that calls for considerable 
will and power. In this regard, the centralisation of ASC in two metropolitan areas in 
England (i.e., London and Greater Manchester) is a commendable achievement that 
has been shown to improve clinical and cost outcomes.20 However, different 
approaches in policy implementation have seen better access to care in London than in 
Greater Manchester, where Lynne Horner resided. The present case thus provides a 
strong indication for the evaluation of the current systems of care in terms of 
stakeholder engagement, implementation strategy, protocol compliance, training and 
quality assurance. Equitable access to care in other parts of the country, especially 
remote areas, also needs to be addressed.  
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A variety of policy responses are possible. In Illinois, US, for example, a ‘stroke bill’ was 
signed into law in 2014 whereby a tiered system of hospital network, coupled with 
ambulance transport protocols, would ensure that patients will be treated at the highest 
possible level of care available in their area.21 In the UK, National Health Service (NHS) 
England has recently announced plans to set new performance targets for the 
ambulance service in dealing with ‘rapid life-changing care for conditions such as 
stroke’.22 It adopts a condition-specific approach so that critically ill patients can receive 
not only expeditious but also the most appropriate form of care. The effectiveness and 
necessity of these strategies remains to be determined.  
 
The present case of Lynne Horner is unlikely to be a one-off, and the possibility that 
substandard ACS will give rise to future claims against corporate bodies cannot be 
over-emphasiszed. Stroke-related claims are expensive, and future litigation will  to the 
already mounting medico-legal costs to the NHS that can potentially offset any savings 
from  centralisation of services.23 Civil litigation aside, it is worth remembering that 
mismanaged stroke can be fatal which raises, at least theoretically, the possibility of 
gross negligence manslaughter charges brought against hospital trusts under the 
Corporate Manslaughter and Corporate Homicide Act 2007. Corporate liability might 
conceivably be found where there is a ‘gross breach of duty’ in the management and 
organisation of established and committed stroke services.24 A collective responsibility 
exists for healthcare providers to implement and strengthen ASC at both policy and 
clinical levels.  
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Conclusion  
 
The tragic case of Lynne Horner emphasises how contemporary ASC can be fraught 
with medico-legal challenges. Although the setting of national strategies and 
professional guidelines to improve stroke treatment is a positive development, it does, 
like other guidelines, expose a host of healthcare professionals or even informal carers 
to risks of negligence litigation when they are not followed. The outcome of the present 
case and available clinical evidence suggest that prompt  provision of IVT and MT may  
become legally required standards of care, and that the evidence of their  efficacy  may 
fulfil  the burden of proof of causation in future claims. Effective systems of care must be 
implemented  and should be  a top priority within and beyond metropolitan areas within 
the UK and  world-wide. 
 
The need  to develop integrated ACS worldwide raises important resource allocation 
issues; any payouts to litigants will be come out of  money used to run national care 
systems and so increase financial pressures on them. Urgent and concerted efforts are 
needed to improve matters which should include  effective communication of the best 
treatment regimes  to all professionals  (e.g. paramedics, general practitioners, 
emergency physicians), review and updating of Standard Operating Procedures, and 
education  of the wider public.  Substandard stroke care is not just disastrous for the 
patient it may become expensive for its providers. 
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